Curation of Scientific Content @Leaders in Pharmaceutical Business Intelligence (LPBI) Group, Boston
Author: Aviva Lev-Ari, PhD, RN
Aviva Lev-Ari, PhD, RN is the Editor-in-Chief of the BioMed E-Series of Leaders in Pharmaceutical Business Intelligence (LPBI) Group, Boston
https://pharmaceuticalintelligence.com/biomed-e-books/
UPDATED on 4/5/2018
e-Scientific Publishing: The Competitive Advantage of a Powerhouse for Curation of Scientific Findings and Methodology Development for e-Scientific Publishing – LPBI Group, A Case in Point – Updated on 4/2/2018
Our Publication process involves the following steps:
Step #1:
Identification of EXPERTS, AUTHORS, WRITERS (EAWs)
https://pharmaceuticalintelligence.com/contributors-biographies/experts-authors-writers-eaws/
EXPERTS, AUTHORS, WRITERS (EAWs) CURATE ORIGINAL SCIENTIFIC ARTICLES
EXPERTS, AUTHORS, WRITERS (EAWs) REPORT on Scientific Breakthroughs or Agendas of Conferences of TIGHTEST relevance to our Journal domain of Expertise:
Our DOMAINS in Scientific Media
- Pharmaceutical: Biologics, Small Molecules, Diagnostics
- Life Sciences: Genomics and Cancer Biology
III. Patient-centered Medicine: Focus on #1: Cardiovascular, #2: Cancer, #3: Physiology Metabolomics, Immunology
- Biomedicine, BioTech, and MedTech (Medical Devices)
- HealthCare: Patient-centered Medicine and Personalized/Precision Medicine
Step #2:
Identification of EDITORS
https://pharmaceuticalintelligence.com/contributors-biographies/senior-editors/
EXPERTS Editors, — ONLY — Medical Doctors, PhDs, MD/PhDs, PharmDs — are creating a CREATIVE EXPERTISE DRIVEN electronic Table of Contents (eTOCs) — ONE OF A KIND per each volume — NOT IN EXISTENCE ANYWHERE ON THE INTERNET — not derived from consultation with other textbooks — not in existence in any public domain source
Step #3:
ALL our articles adhere to the strictest REFERENCE CITATION AND SOURCE CITATION STANDARDS
Step #4:
We publish ALL our articles FIRST on
http://pharmaceuticalintelligence.com
eReadership on 8/11/2016 1,032,865
Step #5:
EXPERTS Editors of our e-Books, are ALL — Medical Doctors, PhDs, MD/PhDs, PharmDs — ONLY — these requirements fulfilled AND a substantial LIST OF PUBLICATIONS entitles EAWs to become Editors and are granted the level of privilege of editing the written articles of other EAWs – the role of Editors.
EXPERTS Editors of our e-Books, are ALL — Medical Doctors, PhDs, MD/PhDs, PharmDs — ONLY they SELECT ARTICLES FOR INCLUSION in e-Books from our Archived REPOSITORY
On 8/11/2016 the Web site statistics included the following data:
- 4,815 Scientific Articles,
- 491 Research Categories (Journal Ontology), and
- 9,433 Scientific Tags
- 7,261 Scientific COmments
Step #6:
All volumes are converted to .mobi format for KINDLE platform
Step #7:
All converted volumes are PROOFREAD BY TWO EDITORS
Step #8:
Editor-in-Chief is the ONLY authority authorizing the UPLOAD to Amazon.com of a ready to be published e-Book
Thus, we have published EIGHT e-Books in MEDICINE and Life Sciences
WE ARE ON AMAZON.COM
http://www.amazon.com/dp/B00DINFFYC
http://www.amazon.com/dp/B018Q5MCN8
http://www.amazon.com/dp/B018PNHJ84
http://www.amazon.com/dp/B018DHBUO6
http://www.amazon.com/dp/B013RVYR2K
http://www.amazon.com/dp/B012BB0ZF0
http://www.amazon.com/dp/B019UM909A
http://www.amazon.com/dp/B019VH97LU
SEVEN VOLUMES are forthcoming in 2016-2017:
- ALL our e-Books contain Expert driven eTOCs demonstrating an ORIGINAL thought process and represent the FRONTIER of the STATE of Science in every case.
- ALL our e-Books comprise of articles published first on http://pharmaceuticalintelligence.com
- EVERY article upon publication is CONNECTED by the Expert, Author Writer to the following channels of SOCIAL MEDIA
Our Channels on Social Media and Internet Presence include:
- Our Journal +1,031,000 eReaders on 8/11/2016
http://pharmaceuticalintelligence.com
- Aviva’s – +6000 BIOTECH followers on LinkedIn
http://www.linkedin.com/in/avivalevari
- LPBI Group’s FaceBook Page
http://www.facebook.com/LeadersInPharmaceuticalBusinessIntelligence
- LPBI Group’s Twitter Account
- Aviva Manages three Groups on LinkedIn
Cardiovascular Biotech & Pharma UK & US Networking Group
https://www.linkedin.com/groups/4357927
Leaders in Pharmaceutical Business Intelligence
https://www.linkedin.com/groups/4346921
https://www.linkedin.com/groups/2987122
- LPBI Group’s Company’s Page on LinedIn
Lastly, please review,
Key Opinion Leader (KOL) – Aviva Lev-Ari, PhD, RN, as evidenced by
Curator: Aviva Lev-Ari, PhD, RN
Leave a Reply